Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,641,906
  • Shares Outstanding, K 103,796
  • Annual Sales, $ 4,390 M
  • Annual Income, $ 24,280 K
  • 60-Month Beta 1.52
  • Price/Sales 1.47
  • Price/Cash Flow 12.02
  • Price/Book 2.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.89
  • Number of Estimates 5
  • High Estimate 0.91
  • Low Estimate 0.88
  • Prior Year 0.89
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.62 +15.05%
on 12/18/19
64.72 -1.14%
on 01/15/20
+7.98 (+14.25%)
since 12/17/19
3-Month
47.35 +35.14%
on 11/08/19
64.72 -1.14%
on 01/15/20
+8.62 (+15.57%)
since 10/17/19
52-Week
36.72 +74.26%
on 02/28/19
64.72 -1.14%
on 01/15/20
+15.38 (+31.64%)
since 01/17/19

Most Recent Stories

More News
Indegene's SaaS Platform For Life Sciences Adds Syneos Health as Strategic Collaborator and Minority Investor

Indegene, a leading Healthcare Tech firm focused on the global life sciences industry, announced Syneos Health (NASDAQ: SYNH) as a strategic collaborator and minority investor in Indegene Omnipresence...

SYNH : 63.99 (+0.20%)
Indegene's SaaS Platform For Life Sciences Adds Syneos Health as Strategic Collaborator and Minority Investor

Indegene, a leading Healthcare Tech firm focused on the global life sciences industry, announced Syneos Health (NASDAQ: SYNH) as a strategic collaborator and minority investor in Indegene Omnipresence...

SYNH : 63.99 (+0.20%)
Syneos Health Announces Strategic Collaboration and Investment in Indegene Omnipresence and the Company's Next-Generation CRM and Omnichannel Engagement SaaS Platform

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced a strategic collaboration and minority investment in Indegene Omnipresence and the company's next-generation...

SYNH : 63.99 (+0.20%)
5 Best Value Picks to Grab on Discounted PEG

Value investors with varied risk appetite are unlikely to consider price/earnings to growth (PEG) ratio among a number of other popular metrics.

AES : 20.50 (-0.34%)
CACI : 270.61 (+0.42%)
HRC : 115.75 (-0.51%)
BBBY : 15.39 (+0.20%)
SYNH : 63.99 (+0.20%)
Syneos Health to Present at the 38th Annual J.P. Morgan Healthcare Conference

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

JPM : 138.20 (+0.69%)
SYNH : 63.99 (+0.20%)
Syneos Health (SYNH) Hits a 52-Week High: What's Driving It?

Syneos Health (SYNH) gains from several positive developments.

OMCL : 85.93 (-1.82%)
HAE : 113.85 (-1.86%)
NUVA : 78.10 (-1.59%)
SYNH : 63.99 (+0.20%)
Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization

The Syneos Health Insights Hub, a dynamic destination for what's next thinking and future-focused insights, today released 2020 Health Trends: Changing Lives and Life Sciences. This annual trends report...

SYNH : 63.99 (+0.20%)
Working and Rallying

Working and Rallying

GTES : 13.24 (-0.45%)
SLP : 33.86 (+1.77%)
PTF : 82.84 (+0.42%)
CUB : 69.85 (+1.00%)
DOMO : 24.11 (-3.44%)
SYNH : 63.99 (+0.20%)
CMTL : 36.26 (-1.06%)
XPER : 18.71 (+0.32%)
MSI : 176.12 (+1.89%)
SYNH vs. HMSY: Which Stock Should Value Investors Buy Now?

SYNH vs. HMSY: Which Stock Is the Better Value Option?

SYNH : 63.99 (+0.20%)
HMSY : 28.73 (-3.46%)
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released "Real World Value: Advancing Payer Understanding of RWE in Rare Disease," a report identifying...

SYNH : 63.99 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SYNH with:

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

2nd Resistance Point 65.04
1st Resistance Point 64.51
Last Price 63.99
1st Support Level 63.39
2nd Support Level 62.80

See More

52-Week High 64.72
Last Price 63.99
Fibonacci 61.8% 54.03
Fibonacci 50% 50.72
Fibonacci 38.2% 47.42
52-Week Low 36.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar